The WHO ranked a new variant of Omicron into the 'worrying' row with the level with Delta variant - which part was worried, but the Vaccine firms said it was quickly planning to deal. A new Covid-19 variant Newly discovered in South Africa and November 26 are named by the World Health Organization (WHO) as Omicron.Omicron located with "worrying" as Deltang 26-11, WHO experts meeting reviews The new Omicron variant - is given a large number of mutations in the protein string of the SARS-COV-2 virus that helps the variant capable of spreading strongly. The exact data on the risks of the Omicron variant may have to be a few more weeks to collect all, but WHO leads many initial movements and assessed that this variant can increase the risk of transmission. Omicron variations are lined by the WHO to the list of "worrying" variants - the same level with Delta variation
. However, the threatening level of the Omicron variant with public health has not been clearly defined. Before Omicron, the Beta variant was also considered by WHO as a "worrying" variant but then reality showed that this variant did not spread widely and endangers as much as the original concern. South African people get vaccinated Covid-19 is close to Johannesburg TP in Gauteng Prefecture
Photo: APDU WHO suggested countries to enhance the path monitoring of the Omicron variant and efforts to explain the genome to better understand its potential impact. The vaccine firms quickly enter the Word of Y experts Tecology is likely to be more weeks that the new world gets precise data whether the Omicron variant can reduce the effectiveness of existing vaccines. However, many developers, production firms Vaccine has spent reassuring that he has plans to deal, according to AP news agency Moderna (USA) said he has been strategic 3 points to deal a new variant of Omicron. The mutation of Omircon variant Ability to reduce the effectiveness of current vaccines, however, the great ability will not be able to eliminate the benefits of vaccines, according to Dr. Ashish JHA - Principal of Brown University Public Health School (USA). " There are a series of mutations in important areas that can affect the effectiveness of our vaccines. But do I make the vaccine useless? Are not. This super uncomfortable "- Dr. Jha wrote on Twitter on November 26.Trong strategy, Moderna outlined 3 options on increasing Covid-19 vaccination
3 This option, according to the press release that Moderna announces on November 26 is: Injecting additional additional doses; The dose that currently Moderna is studying to target mutations in Omicron variations; And special doses are dedicated to targeting Omicron variations - which Moderna has shone researching. On the Twitter on November 26, Expert Andy Slavitt - once the White House Advisor on Reaction with Covid-19 for Covid-19 Knowing both Moderna and Pfizer / Biontech, it will need 3 months to develop a vaccine against a new variation. Not to mention the time needed to handle procedures for permission as well as logistics later. "If we start in early December, new vaccines will probably be available in the summer in most of so Gender "- Mr. Slavitt wrote on Twitter. November 26, a series of media companies reported that Pfizer / Biontech was studying the new Omicron variant and expects data to be available for several weeks. If this process is guaranteed, an Omicron variant targeting variant can be developed within 6 weeks and shipped within 100 days. Johnson . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
